NAV as on Aug 31, 2021:
|Performance of Nippon India Pharma Fund as on 31/08/2021|
|Particulars||1 Year CAGR %||3 Year CAGR %||5 Year CAGR %||Since Inception|
|Nippon India Pharma Fund ||47.96||24.91||16.97||22.14|
|B: S&P BSE Healthcare TRI||45.33||19.37||11.17||16.26|
|AB: S&P BSE Sensex TRI||50.55||15.49||16.48||17.02|
|Nippon India Pharma Fund|| 14,796 || 19,501 || 21,906 || 3,15,078 |
|B: S&P BSE Healthcare TRI|| 14,533 || 17,017 || 16,985 || 1,34,476 |
|AB: S&P BSE Sensex ?TRI|| 15,055 || 15,412 || 21,451 || 1,50,518 |
Inception Date: Jun 5, 2004|
|B - Benchmark | AB - Additional Benchmark | TRI - Total Return Index |
|Fund Manager: Sailesh Raj Bhan (Since Jun 2004)|
|As TRI data is not available since Since Inception of the scheme, benchmark performance is calculated using composite CAGR of S&P BSE HC PRI values from date 04-Jun-2004 to date 23-Aug-2004 and TRI values since date 23-Aug-2004. |
PERFORMANCE OF OTHER OPEN ENDED SCHEMES MANAGED BY FUND MANAGER: Sailesh Raj Bhan
|Scheme Name/s||CAGR %|
|1 Year Return ||3 Years Return||5 Years Return|
|Scheme ||Benchmark ||Scheme ||Benchmark ||Scheme ||Benchmark |
|Nippon India Multi Cap Fund||66.15||64.92||12.28||14.92||12.66||15.62|
|Nippon India Large Cap Fund||53.69||53.12||11.08||14.48||13.41||15.46|
a.Mr. Sailesh Raj Bhan manages 3 open-ended schemes of Nippon India Mutual Fund.
b. In case the number of schemes managed by a fund manager is more than six, in the performance data of other schemes, the top 3 and bottom 3 schemes managed by fund manager has been provided herein.
c. Period for which schemes performance has been provided is computed basis last day of the month-end preceding the date of advertisement.
d. Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).
TRI - Total Returns Index reflects the returns on the index arising from (a) constituent stock price movements and (b) dividend receipts from constituent index stocks, thereby showing a true picture of returns.
The performance of the equity scheme is benchmarked to the Total Return variant of the Index.
Mr. Sailesh Raj Bhan has been managing Nippon India Pharma Fund since Jun 2004, Nippon India Multi Cap Fund since Mar 2005, Nippon India Large Cap Fund since Aug 2007
Past performance may or may not be sustained in future and the same may not necessarily provide the basis for comparison with other investments. Returns for 1 year and above are compounded annualized(CAGR) and returns less than 1 yearare simple annualized basis. 6 months simple annualized returnsare provided for the schemes that are in existence for more than 6 months but have not completed 1 year.Dividend (if any) are assumed to be reinvested at the prevailing NAV. In case of LIQUIDBEES, returns are based on gross dividend per unit declared by the Fund. Bonus (if any) declared has been adjusted. Performance of IDCW option would be net of dividend distribution tax, if any. Face value of schemes is
`10 per unit, except for the schemes as specified here. Face Value of Nippon India Liquid Fund, Nippon India Money Market Fund Nippon India Ultra Short Duration Fund, Nippon India Low Duration Fund and Nippon India ETF Liquid BeES is
`1000 per unit. Face value of Nippon India ETF Junior BeES is
`1.25 per unit. Face value of Nippon India Overnight Fund is
`100 per unit. Face Value of Nippon India ETF Nifty BeES, Nippon India ETF Bank BeES, Nippon India ETF PSU Bank BeES, Nippon India ETF NV20, Nippon India ETF Hang Seng BeES, Nippon India ETF Gold BeES is
`1 per unit. In case, the start/end date of the concerned period is non-business day, NAV of the previous date is considered for computation of returns. Performance details of closed ended and interval schemes are not provided since these are not comparable with other schemes. Different plans shall have a different expense structure. The performance details provided herein are of Growth Plan (Regular Plan).